Alan Glicklich serves as Executive at CHINOOK THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Alan Glicklich has executed 6 insider transactions totaling $357.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 11, 2022 involved selling 2,391 shares valued at $30.5K.
Alan Glicklich currently holds 7,891 shares of CHINOOK THERAPEUTICS, INC. (KDNY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alan Glicklich has been a net seller of KDNY stock. They have purchased $0 and sold $357.5K worth of shares.
Alan Glicklich's most recent insider trade was on Feb 11, 2022, when they sold 2,391 shares at $12.74 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 6, 2021 | KDNY | $0 | Option Exercise | 7,103 | $N/A | Discretionary |
| Oct 6, 2021 | KDNY | $30.8K | Payment | 2,489 | $12.37 | Discretionary |
| Jun 16, 2021 | KDNY | $8.4K | Option Exercise | 20,000 | $0.42 | Discretionary |
| Jun 16, 2021 | KDNY | $327.0K | Sale | 20,000 | $16.35 | Discretionary |